All In MedTech

FDA Clearance Tracker · P030050-S002

SCULPTRA AESTHETIC

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 28, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 28, 2009

Approved

Time to decision

1,096 days

Received Jul 28, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P030050-S002
Device name
SCULPTRA AESTHETIC
Applicant
Q-Med AB
Applicant location
Uppsala
Received
Jul 28, 2006
Decided
Jul 28, 2009
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P030050

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR SCULPTRA AESTHETIC. THE DEVICE IS INDICATED FOR USE IN IMMUNE-COMPETENT PEOPLE AS A SINGLEREGIMEN FOR CORRECTION OF SHALLOW TO DEEP NASOLABIAL FOLD CONTOUR DEFICIENCIES AND OTHER FACIALWRINKLES IN WHICH DEEP DERMAL GRID PATTERN (CROSS-HATCH) INJECTION TECHNIQUE IS APPROPRIATE.

Source documents

Other decisions for Q-Med AB

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.